Literature DB >> 35141084

Concurrent Presentation of Diabetic Nephropathy and Type 1 Diabetes Mellitus in a Pediatric Patient.

Sana Manazir1, Hafiza M Durrani2, Fatima Jawed3, Hira Iqbal Naviwala1.   

Abstract

Diabetic nephropathy (DN) is the most consequential and longstanding microvascular complication of type 1 diabetes mellitus (T1DM) and the most common cause for renal replacement therapy throughout the world. The most important risk factor for DN includes poor glycemic control. We present a rare case where biopsy-proven grade 3 DN had a concurrent presentation at the time of diagnosis of T1DM in a 12-year-old female child. This earlier than expected DN noted in this patient raises the question regarding the need for earlier surveillance for DN in children.
Copyright © 2021, Manazir et al.

Entities:  

Keywords:  diabetic nephropathy (dn); endocrinology and diabetes; glycated haemoglobin (hba1c); pediatrics; type 1 diabetes mellitus (t1dm)

Year:  2021        PMID: 35141084      PMCID: PMC8800391          DOI: 10.7759/cureus.20831

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  6 in total

1.  Prevalence of Diabetes and Diabetic Nephropathy in a Large U.S. Commercially Insured Pediatric Population, 2002-2013.

Authors:  Lin Li; Susan Jick; Stefanie Breitenstein; Alexander Michel
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

Review 2.  Diabetic nephropathy in type 1 diabetes.

Authors:  Nektaria Papadopoulou-Marketou; Stavroula A Paschou; Nikolaos Marketos; Sofia Adamidi; Sotiris Adamidis; Christina Kanaka-Gantenbein
Journal:  Minerva Med       Date:  2017-12-04       Impact factor: 4.806

3.  Early Diabetic Nephropathy and Retinopathy in Patients with Type 1 Diabetes Mellitus Attending Sudan Childhood Diabetes Centre.

Authors:  Hana Ahmed; Tayseer Elshaikh; Mohamed Abdullah
Journal:  J Diabetes Res       Date:  2020-11-24       Impact factor: 4.011

Review 4.  Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis.

Authors:  Nektaria Papadopoulou-Marketou; George P Chrousos; Christina Kanaka-Gantenbein
Journal:  Diabetes Metab Res Rev       Date:  2016-10-04       Impact factor: 4.876

Review 5.  A Practical Review of C-Peptide Testing in Diabetes.

Authors:  Emma Leighton; Christopher Ar Sainsbury; Gregory C Jones
Journal:  Diabetes Ther       Date:  2017-05-08       Impact factor: 2.945

6.  HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study.

Authors:  Marcus Lind; Aldina Pivodic; Ann-Marie Svensson; Arndis F Ólafsdóttir; Hans Wedel; Johnny Ludvigsson
Journal:  BMJ       Date:  2019-08-28
  6 in total
  1 in total

Review 1.  Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy.

Authors:  Chunkang Liu; Kunzhe Wu; Huan Gao; Jianyang Li; Xiaohua Xu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-08-31       Impact factor: 3.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.